Mannkind (MNKD) Interest & Investment Income (2010 - 2026)
Mannkind's (MNKD) quarterly Interest & Investment Income came in at $1.4 million in Q1 2026, down 26.94% year-on-year from $2.0 million in Q1 2025, and down 12.71% on a QoQ basis from $1.6 million in Q4 2025.
Mannkind (MNKD) Interest & Investment Income (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Interest & Investment Income data on file, last reported at $1.4 million in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 26.94% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $7.5 million, a 32.42% decrease from a year earlier, with the FY2025 full-year figure at $8.1 million, down 36.16% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $1.4 million, down from $1.6 million in the prior quarter.
- Over the last five years, Interest & Investment Income for MNKD reached as high as $3.4 million in Q1 2024 and fell as low as $377000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $1.8 million across 5 years, with a median of $1.6 million in 2025.
- Across the five-year window, Interest & Investment Income surged 12466.67% in 2022 and slumped 43.04% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $957000.0 in 2022, then jumped by 80.25% to $1.7 million in 2023, then surged by 63.77% to $2.8 million in 2024, then tumbled by 42.05% to $1.6 million in 2025, then slipped by 12.71% to $1.4 million in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $1.4 million in Q1 2026, $1.6 million in Q4 2025, and $2.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Mannkind | 1.23 Bn | 1.10 Bn | 82.66 Mn | 1.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.43 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 2.63 Mn |
| Jun 30, 2025 | 1.83 Mn |
| Mar 31, 2025 | 1.96 Mn |
| Dec 31, 2024 | 2.83 Mn |
| Sep 30, 2024 | 3.18 Mn |
| Jun 30, 2024 | 3.18 Mn |
| Mar 31, 2024 | 3.43 Mn |
| Dec 31, 2023 | 1.73 Mn |
| Sep 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 1.55 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 957,000.00 |
| Sep 30, 2022 | 663,000.00 |
| Jun 30, 2022 | 516,000.00 |
| Mar 31, 2022 | 377,000.00 |
| Dec 31, 2021 | 48,000.00 |
| Sep 30, 2021 | 36,000.00 |
| Jun 30, 2021 | 25,000.00 |